SMHBETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN
Provides 2x leveraged monthly-compounded exposure to the Solactive US Small Cap High Dividend Index, less Accrued Fees.
By UBS · Launched 2018
0.85%
#4,336 of 5,562 · expensive
$20M
#4,344 of 5,562 · small
+7.4%
7 years
#1,845 of 5,562 · established
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Index tracked
Solactive US Small Cap High Dividend Index
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Provides 2x leveraged monthly-compounded exposure to the Solactive US Small Cap High Dividend Index, less Accrued Fees.
- Strategy
- Provides 2x leveraged long exposure to the compounded monthly performance of the Solactive US Small Cap High Dividend Index — U.S.-listed small-cap high-dividend equities. Resets on a Monthly Reset Date (not daily-reset) and pays a variable monthly coupon linked to leveraged cash distributions from index constituents, less an Accrued Tracking Fee and Financing Charges.
- Inception date
- November 8, 2018
- Fund family
- UBS
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Leveraged ETF — not a long-term hold
This fund uses leverage to amplify daily returns (e.g. 2x or 3x of an index). Daily rebalancing creates volatility decay — over weeks and months, the fund's return drifts from the stated multiple. In trending markets with low realised volatility, leveraged index ETFs can outperform their nominal multiple; in sideways or volatile markets they bleed. Designed for short-term tactical use, not buy-and-hold.
Source: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)
Why we flagged this: strategy=leveraged + leveraged_name_or_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed SMHB. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-20